002644SZSE

Announcement of Resolutions from the Second Extraordinary Shareholders' Meeting of 2026

Foci Pharmaceutical Co., Ltd.·May 29, 2026·3 pages

✨ AI Summary

The second extraordinary shareholders' meeting of Lanzhou Foci Pharmaceutical Co., Ltd. was held on May 29, 2026. A total of 149 shareholders attended, representing 316,746,956 shares, or 62.03% of the voting rights. The meeting approved the proposal to amend the "Compensation Management System for Directors and Senior Management," with 99.73% voting in favor. Legal counsel confirmed the meeting's compliance with relevant laws and regulations.

Summary generated by AI · Always verify with source document

Exchange Summary

EGM RESOLUTION

The Company held its 2nd Extraordinary General Meeting of 2026 on 29 May 2026, during which the following proposal(s) was/were approved: 1. Amendments to the remuneration management system for directors and senior management

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· azure_openai

Lanzhou Foci Pharmaceutical Co., Ltd.
Announcement No.: 2026-022

This company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Important Notice:

There are no circumstances of adding, changing, or rejecting proposals at this shareholders' meeting.
This shareholders' meeting does not involve changes to the resolutions of the previous shareholders' meeting.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.